Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — taking metformin and Wegovy together is generally considered safe, and many people with type 2 diabetes do exactly that. Both medicines work through different mechanisms, they do not share a dangerous interaction, and prescribers often use them alongside each other when managing blood sugar and weight. That said, these are prescription-only medicines, and whether this combination is right for you depends on your full medical picture, which only a clinician can assess. Metformin lowers blood glucose by reducing the amount your liver produces and improving how cells respond to insulin. Wegovy (semaglutide 2.4 mg) works primarily on the brain's appetite centres via GLP-1 receptors, slowing gastric emptying and reducing how much you want to eat. The two act on entirely different pathways, which is partly why combining them raises few pharmacological concerns — but it also means both need proper clinical oversight.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No clinically significant pharmacokinetic interaction between metformin and semaglutide has been identified. They are absorbed differently, metabolised differently, and excreted differently, so one does not meaningfully change how the other is processed in the body. The BNF entry for semaglutide lists no interaction with metformin that would require dose adjustment or avoidance.
That reassurance is meaningful, but it has a limit. Wegovy slows gastric emptying, and anything that changes how quickly your stomach processes food and fluid can, in theory, alter the absorption timing of oral medicines, including metformin tablets. In practice, for most people this does not produce a measurable problem. Metformin is not heavily dependent on rapid absorption, and its therapeutic effect is sustained rather than peak-dependent. Still, if you notice a change in how your metformin seems to work after starting Wegovy, that is worth raising with your prescriber rather than adjusting anything yourself.
One misconception worth putting to rest: some people assume that because both medicines influence blood sugar, they must interact dangerously. They do not. If you are wondering whether semaglutide is actually present in metformin, the short answer is that these are entirely separate medicines with different active ingredients and different mechanisms. The blood-sugar overlap only becomes relevant if metformin is being pushed to a high dose at the same time as significant weight loss is occurring, which is precisely when a prescriber would review your regimen.
Metformin's main job is keeping fasting blood glucose down, mainly by telling the liver to release less glucose overnight and between meals. Wegovy's effect on blood sugar is a secondary benefit of weight loss and reduced calorie intake rather than a direct glucose-lowering mechanism at the weight-management dose. When the two work together in a person with type 2 diabetes, blood glucose tends to improve, sometimes considerably.
That improvement is welcome, but it introduces a practical question: as your weight falls and your diet changes, do you still need the same metformin dose? Possibly not. The NHS medicines guidance on semaglutide is clear that people with diabetes should monitor their blood glucose regularly when starting or changing GLP-1 treatment and should discuss any dose changes with their doctor. This is not a reason to avoid the combination, it is a reason to stay in contact with whoever is prescribing for you.
For people without diabetes who are taking metformin off-label for other reasons (polycystic ovary syndrome is the most common), the picture is slightly different. Many people ask whether you can take metformin and Wegovy together in that context, and the answer is that a prescriber would weigh up both medicines independently before continuing them alongside each other, since neither is licensed for PCOS and the evidence base is less settled.
This is the practical question most people are really asking. Both metformin and semaglutide have gastrointestinal side effects as their most common profile: nausea, loose stools, an unsettled stomach, reduced appetite. Metformin's GI effects are usually most pronounced at the start of treatment and can be minimised by taking it with food or switching to a modified-release formulation. Semaglutide's GI effects follow a different pattern, they tend to appear after each dose increase and settle over a week or two as the body adjusts.
When taken together, those profiles overlap. Some people find the combination more unsettling than either medicine alone, particularly in the first few weeks of Wegovy or around a dose step-up. A common follow-up question is whether you can take metformin and Wegovy at the same time on the same day, and the practical guidance on timing, hydration and meal size is worth reviewing with your prescriber if GI symptoms are a concern. Severe or persistent vomiting is worth flagging promptly, since dehydration can affect how the kidneys process metformin, a detail your prescriber will be aware of.
If you are weighing up the cost of private treatment alongside existing NHS prescriptions, our treatment overview page sets out what is included in a nume consultation and what to tell our prescribers about your current medicines.
Yes, always, and this applies whether you are starting Wegovy through the NHS or through a regulated private service like nume. Your prescriber needs a complete medicines list before approving any new treatment. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber who will look at your full health picture, including existing prescriptions, before making a clinical decision. No consultation is rubber-stamped.
If you are already established on Wegovy and your GP is considering adding or continuing metformin, the same applies in reverse: your GP should know you are on a GLP-1 medicine. This is not about seeking permission, it is about making sure the doses, monitoring plan and any side-effect management are joined up. The combination is used routinely in clinical practice; the conversation is straightforward. You can read more about semaglutide and metformin more broadly or explore how the two medicines differ if you are still piecing together how they relate to each other.
When you are ready to talk through your own situation, our prescribers are available seven days a week. Speak to our prescribers through a free consultation, same-day review, no subscription, no hidden fees.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.